Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.23.1
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue [Line Items]        
Revenues $ 6,585,967 $ 13,028,394 $ 9,093,761 $ 27,163,526
FC2 [Member]        
Disaggregation of Revenue [Line Items]        
Revenues 6,580,447 13,028,394 9,080,448 27,163,526
FC2, U.S. Prescription Channel [Member]        
Disaggregation of Revenue [Line Items]        
Revenues 4,146,160 11,590,466 4,309,164 23,164,732
FC2, Global Public Health Sector [Member]        
Disaggregation of Revenue [Line Items]        
Revenues 2,434,287 $ 1,437,928 4,771,284 $ 3,998,794
Other [Member]        
Disaggregation of Revenue [Line Items]        
Revenues $ 5,520   $ 13,313